CTOs on the Move

Nexterna

www.nexterna.com

 
Nexterna, Inc. is a Burlington, ON-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.nexterna.com
  • 3060 Mainway Ste 100
    Burlington, ON CAN L7M 1A3
  • Phone: 905.319.8378

Executives

Name Title Contact Details

Similar Companies

PremiTech

PremiTech Inc. is a Iselin, NJ-based company in the Software and Internet sector.

Kinetica

When extreme data requires companies to act with unprecedented agility, Kinetica powers business in motion. Kinetica is the instant insight engine for the extreme data economy. Across healthcare, energy, telecommunications, retail, and financial services, enterprises utilizing new technologies like connected devices, wearables, mobility, robotics, and more can leverage Kinetica for machine learning, deep learning, and advanced location-based analytics that are powering new services. Kinetica`s accelerated parallel computing brings thousands of GPU cores to address the unpredictability and complexity that result from extreme data. Kinetica has a rich partner ecosystem, including NVIDIA, Dell, HP, and IBM, and is privately held, backed by leading global venture capital firms Canvas Ventures, Citi Ventures, GreatPoint Ventures, and Meritech Capital Partners.

xSynthesis

xSynthesis is a Leesburg, VA-based company in the Software and Internet sector.

Vivantio

Vivantio is a Redwood City, CA-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.